Browser Not Supported

It looks like you're using an outdated browser. To view this site properly, please switch to a more modern browser such as Chrome,Firefox, or Edge.

Mouthcare prophylaxis protocol

Date last published:

Patients should start off with different levels of mouthcare depending on the mucositis potential of their therapy. As mucositis occurs then additional therapies should be added in.

This document is only valid for the day on which it is accessed. Please read our .
Child cancer

Introduction

Patients should start off with different levels of mouthcare depending on the mucositis potential of their therapy. As mucositis occurs then additional therapies should be added in. (See Treatment of Established Mucositis in Mouth care and Mucositis guideline.)

Group A: Protocols with very high Mucositis-inducing potential

  • AML

  • Autologous stem cell rescue

  • Allogenic stem cell transplantation

Therapy

Group B: Protocols with high Mucositis-inducing potential

  • ALL - Induction and reinduction/reconsolidation blocks

  • Relapsed ALL

  • Multi-agent therapy for poor prognosis solid tumours

  • Infant ALL - all phases except maintenance

  • High risk Neuroblastoma

  • Ewings sarcoma protocols

  • Osteosarcoma protocols

  • High risk B-cell NHL protocols

  • Anaplastic Large Cell Lymphoma protocol

  • Brain Tumour patients receiving chemotherapy or radiation therapy and Dexamethasone.

Therapy

Group C: Standard risk (low Mucositis-inducing potential)

All other patients receive basic mouthcares only.

Tools